Cationic polymers and porous materials
US-2019040159-A1 · Feb 7, 2019 · US
US11565942B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11565942-B2 |
| Application number | US-202117230476-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 14, 2021 |
| Priority date | Apr 14, 2021 |
| Publication date | Jan 31, 2023 |
| Grant date | Jan 31, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are modified zeolites and methods for making modified zeolites. In one or more embodiments disclosed herein, a modified zeolite may include a microporous framework including a plurality of micropores having diameters of less than or equal to 2 nm. The microporous framework may include at least silicon atoms and oxygen atoms. The modified zeolite may further include organometallic moieties each bonded to bridging oxygen atoms. The organometallic moieties may include a platinum atom. The platinum atom may be bonded to a bridging oxygen atom, and the bridging oxygen atom may bridge the platinum atom of the organometallic moiety and a silicon atom of the microporous framework.
Opening claim text (preview).
The invention claimed is: 1. A modified zeolite comprising: a microporous framework comprising a plurality of micropores having diameters of less than or equal to 2 nm, wherein the microporous framework comprises at least silicon atoms and oxygen atoms; and organometallic moieties each bonded to bridging oxygen atoms, wherein the organometallic moieties comprise a platinum atom, wherein the platinum atom is bonded to a bridging oxygen atom, and wherein the bridging oxygen atom bridges the platinum atom of the organometallic moiety and a silicon atom of the microporous framework. 2. The modified zeolite of claim 1 , further comprising a plurality of mesopores having diameters of greater than 2 nm and less than or equal to 50 nm. 3. The modified zeolite of claim 1 , wherein the average pore size of the modified zeolite is greater than 2 nm. 4. The modified zeolite of claim 1 , wherein the organometallic moieties comprise platinum coordinated with one or more ligands, wherein the ligands comprise any of an alkyl group, an aryl group, a dienyl group, a pyridyl group, a cyclooctadienyl group, a cyclopentadienyl group, a quinolinyl group, a halogen group, or a sulfide group. 5. The modified zeolite of claim 1 , wherein the organometallic moieties comprise (1,5-cyclooctadiene)(methyl)platinum(II). 6. The modified zeolite of claim 1 , wherein the microporous framework further comprises aluminum atoms. 7. The modified zeolite of claim 1 , wherein the modified zeolite is a ZSM-5 zeolite. 8. The modified zeolite of claim 1 , wherein the modified zeolite comprises particles of from 25 nm to 900 nm in size. 9. A method for making a modified zeolite, the method comprising: reacting an organometallic chemical with a dehydroxylated zeolite, wherein the dehydroxylated zeolite comprises a microporous framework comprising a plurality of micropores having diameters of less than or equal to 2 nm, wherein the microporous framework comprises at least silicon atoms and oxygen atoms, and wherein the dehydroxylated zeolite comprises isolated terminal silanol functionalities comprising hydroxyl groups bonded to silicon atoms of the microporous framework; wherein the reacting of the organometallic chemical with the dehydroxylated zeolite forms the modified zeolite comprising the microporous framework comprising a plurality of micropores having diameters of less than or equal to 2 nm, wherein the microporous framework comprises at least silicon atoms and oxygen atoms, and organometallic moieties each bonded to bridging oxygen atoms, wherein the organometallic moieties comprise a platinum atom, wherein the platinum atom is bonded to a bridging oxygen atom, and wherein the bridging oxygen atom bridges the platinum atom of the organometallic moiety and a silicon atom of the microporous framework, wherein the organometallic moiety comprises a portion of the organometallic chemical; wherein the organometallic chemical comprises platinum. 10. The method of claim 9 , wherein the modified zeolite comprises a plurality of mesopores having diameters of greater than 2 nm and less than or equal to 50 nm. 11. The method of claim 9 , wherein the average pore size of the modified zeolite is greater than 2 nm. 12. The method of claim 9 , further comprising dehydroxylating an initial zeolite to form the dehydroxylated zeolite, wherein the initial zeolite primarily comprises vicinal silanol functionalities, and wherein dehydroxylating the initial zeolite forms the isolated terminal silanol functionalities. 13. The method of claim 12 , wherein one or more of: dehydroxylating the initial zeolite comprises heating the initial zeolite at a temperature of 650° C. to 1100° C.; and dehydroxylating the initial zeolite is under reduced pressure. 14. The method of claim 9 , wherein the microporous framework further comprises aluminum atoms. 15. The method of claim 9 , wherein the organometallic chemical comprises platinum coordinated with one or more ligands, wherein the ligands comprise any of an alkyl group, an aryl group, a dienyl group, a pyridine group, a cyclooctadienyl group, a cyclopentadienyl group, a quinolone group, a halogen group, or a sulfide group. 16. The method of claim 9 , wherein the organometallic chemical comprises (1,5-cyclooctadiene)(dimethyl)platinum(II). 17. The method of claim 9 , wherein the organometallic moieties of the modified zeolite comprise platinum coordinated with one or more ligands, wherein the ligands comprise any of a pyridine group, a cyclooctadienyl group, a cyclopentadienyl group, a quinolone group, a halogen group, or a sulfide group. 18. The method of claim 9 , wherein the organometallic moieties of the modified zeolite comprise (1,5-cyclooctadiene)methylplatinum(II). 19. The method of claim 9 , wherein the average pore size of the dehydroxylated zeolite is greater than the size of the organometallic chemical.
the impregnation liquid containing organic compounds · CPC title
Operations & Transport · mapped topic
After-treatment · CPC title
Reducing · CPC title
Operations & Transport · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.